𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Megestrol acetate: Phase II study of a single daily administration in advanced breast cancer

✍ Scribed by Paolo Pronzato; Fulvio Brema; Domenico Amoroso; Gianfilippo Bertelli; Pier Franco Conte; Maria Cristina Martini; Gisella Pastorino; Riccardo Rosso


Publisher
Springer US
Year
1990
Tongue
English
Weight
307 KB
Volume
17
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase II study of high-dose medroxypro
✍ Geoffrey Falkson; HΓ¨ndrΓ© C. Falkson πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 215 KB

Twenty-three evaluable patients with advanced breast cancer were treated with MPA, 1,400 mg/m2 daily PO for the first 6 months, and 500 mg/m2 daily PO thereafter. The median total dose was 191,400 mg in 88 days, with the maximum dose given to date 522,600 mg in 282 days. Most patients tolerated high

A phase II study of peptichemio in advan
✍ V. Hug; G. N. Hortobagyi; A. U. Buzdar; G. R. Blumenschein; W. Grose; M. A. Burg πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 445 KB πŸ‘ 3 views